Login / Signup

Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT.

Mouhamed Yazan Abou-IsmailAdam J KanackNoah P SplinterKristi J SmockKaren A MoserAnand Padmanabhan
Published in: Blood advances (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus